Literature DB >> 2076479

The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.

A Butler1, C J Elswood, J Burridge, S J Ireland, K T Bunce, G J Kilpatrick, M B Tyers.   

Abstract

1. The pharmacological characterization of the 5-HT3 receptors in guinea-pig isolated tissues is described. The tissues used were ileum (longitudinal muscle-myenteric plexus), colon and vagus nerve. The guinea-pig isolated colon is a novel preparation. 2. In the guinea-pig isolated ileum, 5-hydroxytryptamine (5-HT, 1 x 10(-8)-3 x 10(-5) M) and the selective 5-HT3 receptor agonist 2-methyl-5-HT (3 x 10(-7)-1 x 10(-4) M) caused concentration-related contractions. The 5-HT concentration-response curve was biphasic whilst the 2-methyl-5-HT curve was monophasic. The EC50 value for the low potency portion of the 5-HT curve was 4.1 x 10(-6) M. The EC50 for 2-methyl-5-HT was 1.23 x 10(-5) M. Selective 5-HT3 receptor antagonists caused rightward shifts of the 2-methyl-5-HT curve and the lower potency portion of the 5-HT curve. Neither ketanserin (1 x 10(-6) M) nor methysergide (1 x 10(-5) M) antagonized the responses to 5-HT or 2-methyl-5-HT. 3. In the guinea-pig isolated colon, 5-HT (3 x 10(-7)-3 x 10(-5) M; EC50 2.4 x 10(-6) M) caused contractions which were mimicked by 2-methyl-5-HT (1 x 10(-6)-1 x 10(-4) M; EC50 7.2 x 10(-6) M). Selective 5-HT3 receptor antagonists caused rightward displacements of the 5-HT concentration-response curves. Neither ketanserin (1 x 10-6 M) nor methysergide (1 x 10- 5M) had any effect on responses to 5-HT or 2-methyl- 5-HT. 4. In the guinea-pig isolated vagus nerve, 5-HT (1 x 10-6-3 x 1O-4M) and 2-methyl-5-HT (1 x i0-S- 1 X 10-3m; EC50 7.6 x 10- M) caused depolarizations; at higher concentrations there were afterhyperpolarizations. The maximum response to 2-methyl-5-HT was less than half that to 5-HT. Selective 5-HT3 receptor antagonists caused rightward displacements of the 5-HT concentration-response curves. Antagonists at other 5-HT receptors (ketanserin, 1 x 10- M and methysergide, 1 x 10-6 M) had no effect. 5. The estimated affinity values of 5-HT3 receptor antagonists correlated well between the three models. Phenylbiguanide was inactive as an agonist or antagonist (up to 1 x 1O-4M) in each preparation. 6. Comparisons with antagonist affinity values obtained in the rat isolated vagus nerve revealed marked differences. Antagonists were generally more potent on the rat isolated vagus nerve, although the differences varied considerably between antagonists. 7. The results are discussed in terms of species-related receptor differences.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076479      PMCID: PMC1917730          DOI: 10.1111/j.1476-5381.1990.tb14126.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  [3H] GR67330, a very high affinity ligand for 5-HT3 receptors.

Authors:  G J Kilpatrick; A Butler; R M Hagan; B J Jones; M B Tyers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

2.  Relative activities of substances related to 5-hydroxytryptamine as depolarizing agents of superior cervical ganglion cells.

Authors:  D Wallis; H Nash
Journal:  Eur J Pharmacol       Date:  1981-03-26       Impact factor: 4.432

3.  5-HT3 receptors are membrane ion channels.

Authors:  V Derkach; A Surprenant; R A North
Journal:  Nature       Date:  1989-06-29       Impact factor: 49.962

4.  Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).

Authors:  G J Sanger; D R Nelson
Journal:  Eur J Pharmacol       Date:  1989-01-10       Impact factor: 4.432

5.  1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.

Authors:  G J Kilpatrick; A Butler; J Burridge; A W Oxford
Journal:  Eur J Pharmacol       Date:  1990-06-21       Impact factor: 4.432

6.  Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Eur J Pharmacol       Date:  1989-01-10       Impact factor: 4.432

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Pharmacological properties of phenyldiguanide and other amidine derivatives in relation to those of 5-hydroxytryptamine.

Authors:  F N FASTIER; M A McDOWALL; H WAAL
Journal:  Br J Pharmacol Chemother       Date:  1959-12

9.  The margin of safety of neuromuscular transmission.

Authors:  W D Paton; D R Waud
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

10.  Two kinds of tryptamine receptor.

Authors:  J H GADDUM; Z P PICARELLI
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  28 in total

1.  Pharmacological characterization of the 5-HT receptor-mediated contraction in the mouse isolated ileum.

Authors:  B R Tuladhar; M D Womack; R J Naylor
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Characterization of the 5-hydroxytryptamine receptors mediating contraction in the intestine of Suncus murinus.

Authors:  F A Javid; R J Naylor
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

3.  The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.

Authors:  T Yoshikawa; N Yoshida; M Oka
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

4.  Antagonistic properties of McNeil-A-343 at 5-HT4 and 5-HT3 receptors.

Authors:  A Sagrada; G B Schiavi; E Cereda; H Ladinsky
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

5.  Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells.

Authors:  A G Hope; J A Peters; A M Brown; J J Lambert; T P Blackburn
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

6.  The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.

Authors:  D J Trezise; I Kennedy; P P Humphrey
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

Review 7.  5-HT3 receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

8.  The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.

Authors:  D L Downie; A G Hope; D Belelli; J J Lambert; J A Peters; K R Bentley; L J Steward; C Y Chen; N M Barnes
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Cisapride and a structural analogue, R 76,186, are 5-hydroxytryptamine4 (5-HT4) receptor agonists on the guinea-pig colon ascendens.

Authors:  M R Briejer; L M Akkermans; A L Meulemans; R A Lefebvre; J A Schuurkes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

10.  An in vitro study of the properties of single vagal afferents innervating guinea-pig airways.

Authors:  A J Fox; P J Barnes; L Urban; A Dray
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.